Residue depletion of albendazole and its metabolites in aquacultured yellow perch (Perca flavescens)
Article first published online: 13 DEC 2011
© 2011 Blackwell Publishing Ltd
Journal of Veterinary Pharmacology and Therapeutics
Volume 35, Issue 6, pages 560–562, December 2012
How to Cite
YU, D., EVANS, E. R., HASBROUCK, N., REIMSCHUESSEL, R. and SHAIKH, B. (2012), Residue depletion of albendazole and its metabolites in aquacultured yellow perch (Perca flavescens). Journal of Veterinary Pharmacology and Therapeutics, 35: 560–562. doi: 10.1111/j.1365-2885.2011.01354.x
- Issue published online: 7 NOV 2012
- Article first published online: 13 DEC 2011
- (Paper received 20 June 2011; accepted for publication 3 November 2011)
Yu, D., Evans, E. R., Hasbrouck, N., Reimschuessel, R., Shaikh, B. Residue depletion of albendazole and its metabolites in aquacultured yellow perch (Perca flavescens). J. vet. Pharmacol. Therap. 35, 560–562.
Metabolism and residue depletion studies are conducted to determine the marker residue (MR) of a drug in a target tissue of food animals. The MR is used to monitor potential unauthorized use of drugs. The current work is a continuation of our efforts to study metabolism and depletion profiles of albendazole in multiple finfish species to determine a common MR. The results of this study suggest that albendazole sulfone metabolite could potentially serve as MR for albendazole in yellow perch muscle, similar to channel catfish and hybrid striped bass as reported previously by us.